RecruitingNot ApplicableNCT06690931

Neurofeedback Rehabilitation With FES and VR for PD

Parkinson's Disease Rehabilitation Using Neurofeedback With Functional Electrical Stimulation and Virtual Reality Feedback for Lower Extremities


Sponsor

g.tec medical engineering GmbH

Enrollment

30 participants

Start Date

Dec 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

recoveriX PRO system is a Brain-Computer Interface (BCI) device that combines Motor Imagination (MI), with Functional Electrical Stimulation (FES) and Virtual Reality (VR) as feedback devices. The user wears an electroencephalography (EEG) cap that registers the neural activity during the mental practice. This system allows the user to control the feedback devices (FES +VR) with the MI. The goal of this clinical trial is to know the safety and clinical effectiveness of recoveriX-based treatment for improving motor functions in Parkinson's Disease patients. Researchers will compare the functional results obtained by recoveriX system, to the standard treatment based in FES + VR + MI without monitoring the EEG activity. The questions to answer are: 1. Will Parkinson's patients who undergo recoveriX therapy significantly improve their motor functions? 2. Is the functional improvement achieved with the BCI treatment superior to the standard MI+FES+VR treatment? 3. Is the recoveriX-based therapy as safe as the standard treatment? Participants will have to perform a complete assessment to evaluate their functionality before and after the intervention (motor skills, walking ability, fatigue, impact of the disease in daily living activities). Patients in the BCI group will receive 6 sessions per week during 4 weeks of BCI training with FES and VR feedback (24 sessions in total). Patients in the control group receive 6 sessions of FES + VR therapy per week for 4 weeks (24 sessions in total). Patients in the control group will receive the same instructions as the experimental but will not wear the EEG cap.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a combined rehabilitation approach for people with Parkinson's disease (PD) that uses neurofeedback (real-time brain activity training), functional electrical stimulation (FES — which uses mild electrical pulses to activate muscles), and virtual reality (VR) exercises. The aim is to improve movement and motor control. **You may be eligible if...** - You have been diagnosed with Parkinson's disease - Your disease is in the mild to moderate range (Hoehn & Yahr stages 1–3) - You are between 40 and 80 years old - You are able to walk independently - Your medications and neurological condition are stable **You may NOT be eligible if...** - You have other neurological diseases - You have severe depression or poorly controlled diabetes - You have serious heart, lung, or bone and joint conditions - You have significant vision problems that would interfere with VR - You have a pacemaker or implanted device that may interact with electrical stimulation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBrain-Computer Interface with FES and VR

The intervention utilizes the recoveriX PRO system. This is a neurofeedback therapy device that combines Brain-Computer Interface based motor imagery, functional electrical stimulation (FES), and virtual reality (VR). This approach enables participants to engage in motor imagery exercises while receiving real-time feedback based on neural signals. Participants will complete a total of 24 recoveriX sessions, scheduled at 6 sessions per week, with each session lasting 1 hour.

DEVICEMotor imagery with Functional Electrical Stimulation and Virtual Reality feedback

The participants will train the Motor Imagination (MI) combined with Functional Electrical Stimulation (FES) and Virtual Reality (VR) feedback. Feedback provided to the patients will not be linked to the neural signals. The amount of stimulation delivered by the feedback devices (FES and VR) will be similar to the experimental group.


Locations(1)

g.tec medical engineering GmbH

Schiedlberg, Upper Austria, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06690931


Related Trials